Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - NetShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ascendis Pharma A (ASND) Other Non-Current Assets (2016 - 2025)

Historic Other Non-Current Assets for Ascendis Pharma A (ASND) over the last 10 years, with Q3 2021 value amounting to $2.0 million.

  • Ascendis Pharma A's Other Non-Current Assets rose 3913.43% to $2.0 million in Q3 2021 from the same period last year, while for Sep 2021 it was $2.0 million, marking a year-over-year increase of 3913.43%. This contributed to the annual value of $1.6 million for FY2020, which is 123.64% up from last year.
  • According to the latest figures from Q3 2021, Ascendis Pharma A's Other Non-Current Assets is $2.0 million, which was up 3913.43% from $2.0 million recorded in Q2 2021.
  • Ascendis Pharma A's Other Non-Current Assets' 5-year high stood at $7.9 million during Q2 2019, with a 5-year trough of -$987307.9 in Q4 2018.
  • Over the past 5 years, Ascendis Pharma A's median Other Non-Current Assets value was $1.6 million (recorded in 2020), while the average stood at $3.0 million.
  • Over the last 5 years, Ascendis Pharma A's Other Non-Current Assets had its largest YoY gain of 5405396.16% in 2018, and its largest YoY loss of 143099.36% in 2018.
  • Ascendis Pharma A's Other Non-Current Assets (Quarter) stood at $74178.3 in 2017, then crashed by 1430.99% to -$987307.9 in 2018, then surged by 264.02% to $1.6 million in 2019, then grew by 1.24% to $1.6 million in 2020, then rose by 23.22% to $2.0 million in 2021.
  • Its Other Non-Current Assets stands at $2.0 million for Q3 2021, versus $2.0 million for Q2 2021 and $1.6 million for Q4 2020.